The initial success of Viagra undeniably reshaped the drug landscape, but placing funds in companies primarily reliant on unbranded versions presents a complex picture. Despite early profits were impressive, the expiration of patents and the emergence of cheaper alternatives have diminished market share. Consequently, a thorough evaluation of on… Read More